Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Alivus Life Sciences Ltd.	Income Statement

NSE: ALIVUSEQ BSE: 543322ISIN: INE03Q201024INDUSTRY: Pharmaceuticals

BSE

Rs 1035.10

Open: 1060.00

Today's Range 1034.10

1077.40

NSE
Rs 1044.60
-19.50 ( -1.87 %)

-27.55 ( -2.66 %)

Prev Close: 1062.65

52 Week Range 830.00

1224.00

You can view the Income Statement for the last 5 years.

Market Cap. (Rs.)	12821.04 Cr.	P/BV	4.05	Book Value (Rs.)	257.92
52 Week High/Low (Rs.)	1225/819	FV/ML	2/1	P/E(X)	22.71
Bookclosure	01/09/2025	EPS (Rs.)	45.99	Div Yield (%)	0.00

(Rs. in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00


INCOME
Revenue From Operations [Net]	2551.83	2339.84	2184.77	2047.84	2087.45
Other Operating Revenues	0.00	47.05	98.44	113.38	35.77
Total Operating Revenues	2551.83	2386.88	2283.21	2161.22	2123.21

Other Income	60.41	34.57	12.04	28.96	14.70
Total Revenue	2612.24	2421.45	2295.26	2190.18	2137.92

EXPENSES
Cost Of Materials Consumed	1063.01	1053.50	1058.58	1098.53	1001.56
Operating And Direct Expenses	0.00	2.43	3.17	2.48	2.66
Changes In Inventories Of FG,WIP And Stock-In Trade	3.56	27.35	-56.57	-84.44	41.32
Employee Benefit Expenses	272.47	251.70	258.16	180.18	168.72
Finance Costs	5.37	2.41	1.55	0.55	27.96
Depreciation And Amortisation Expenses	75.36	60.61	53.45	42.09	37.88
Other Expenses	415.51	369.32	345.63	322.18	292.89
Total Expenses	1835.28	1767.32	1663.97	1561.57	1572.99

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	776.97	654.13	631.29	628.61	564.93

Exceptional Items	-25.66	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	751.31	654.13	631.29	628.61	564.93

Tax Expenses-Continued Operations
Current Tax	186.83	162.44	152.21	150.61	137.63
Deferred Tax	0.00	6.06	8.19	11.04	8.57
Total Tax Expenses	186.83	168.50	160.40	161.65	146.20
Profit/Loss After Tax And Before ExtraOrdinary Items	564.48	485.63	470.89	466.96	418.72

Profit/Loss From Continuing Operations	564.48	485.63	470.89	466.96	418.72

Profit/Loss For The Period	564.48	485.63	470.89	466.96	418.72

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	45.99	39.63	38.43	38.11	35.63
Diluted EPS (Rs.)	45.90	39.53	38.38	38.11	35.63

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	275.69	385.96	128.65
Equity Dividend Rate (%)	0.00	250.00	1125.00	1050.00	1050.00

Market

Derivatives

Mutual Fund

IPO

Quick Links

Alivus Life Sciences Ltd.

Income Statement